Perkins Capital Management’s Quest Diagnostics DGX Stock Holding History

Perkins Capital Management’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-1,200	Closed	-$229K	–	92
2025 Q3	$229K	Hold	1,200	–	–	0.2%	70
2025 Q2	$216K	Hold	1,200	–	–	0.22%	68
2025 Q1	$203K	Buy	+1,200	New	+$197K	0.21%	72
2023 Q1	–	Sell	-1,475	Closed	-$231K	–	101
2022 Q4	$231K	Buy	+1,475	New	+$212K	0.24%	75
2022 Q2	–	Sell	-1,475	Closed	-$202K	–	108
2022 Q1	$202K	Hold	1,475	–	–	0.17%	89
2021 Q4	$255K	Hold	1,475	–	–	0.17%	88
2021 Q3	$214K	Buy	+1,475	New	+$216K	0.13%	89
2018 Q3	–	Sell	-1,850	Closed	-$203K	–	135
2018 Q2	$203K	Buy	+1,850	New	+$193K	0.15%	112
2017 Q3	–	Sell	-2,050	Closed	-$228K	–	105
2017 Q2	$228K	Hold	2,050	–	–	0.25%	80
2017 Q1	$201K	Buy	+2,050	New	+$195K	0.21%	90
2015 Q4	–	Sell	-4,300	Closed	-$264K	–	124
2015 Q3	$264K	Sell	4,300 -12,250	-74%	-$856K	0.29%	89
2015 Q2	$1.2M	Buy	16,550 +350	+2%	+$25.8K	1.05%	28
2015 Q1	$1.25M	Buy	16,200 +11,900	+277%	+$852K	1.04%	26
2014 Q4	$288K	Hold	4,300	–	–	0.25%	98
2014 Q3	$261K	Hold	4,300	–	–	0.22%	105
2014 Q2	$252K	Hold	4,300	–	–	0.18%	105
2014 Q1	$249K	Buy	+4,300	New	+$230K	0.17%	108

Other funds holding DGX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Perkins Capital Management's DGX Position: Q4 2025 in Review

Perkins Capital Management sold out of Quest Diagnostics (DGX) in Q4 2025, closing a stake of 1,200 shares — an estimated $229K sold.

Perkins Capital Management first reported a position in DGX in Q1 2014 and held it in 17 quarters. The position peaked at $1.25M in Q1 2015. 1,050 funds tracked by Wall St. Rank hold DGX as of Q4 2025.

Perkins Capital Management reported no remaining Quest Diagnostics position as of Q4 2025 after selling out during the quarter.
Perkins Capital Management sold 1,200 Quest Diagnostics shares in Q4 2025, an estimated $229K.
Perkins Capital Management first reported a position in Quest Diagnostics in Q1 2014 and held it in 17 quarters.
Perkins Capital Management's Quest Diagnostics position peaked at $1.25M in Q1 2015.
1,050 funds tracked by Wall St. Rank held Quest Diagnostics as of Q4 2025.

Based on Perkins Capital Management's 13F filing for Q4 2025, filed 4 Feb 2026.